Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Basal Health vs Ryze Rx

Basal Health
Graded #494

Lower grade

vs+10.5
Ryze Rx
Graded #376

Higher grade

The verdict

Ryze Rx takes it — 58.2/100 to 47.7/100.

Ryze Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ryze Rx is a prescription telehealth platform for weight loss, TRT and peptide therapy, prescribing through board-certified physicians and shipping from US-licensed compounding pharmacies.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBasal Health +1
45
44
Dose & formulationRyze Rx +24
40
64
Clinical oversightRyze Rx +27
48
75
Labs & monitoringRyze Rx +2
50
52
FulfillmentRyze Rx +11
58
69
Contract termsBasal Health +14
55
41
Basal Health · left barRyze Rx · right bar

The numbers

MetricBasal HealthRyze Rx
WeighScore47.7/10058.2/100
GradeCC
Scorecard rank#494#376
SemaglutideNot disclosed$199/mo (starting dose, 3 month plan, compounded)
TirzepatideNot disclosed$199/mo (starting dose, 3 month plan, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Basal Health

Graded #494 · C

Strengths

  • Stated nationwide coverage (50 states + DC)
  • Metabolic-framework positioning rather than single-product
  • Clinician-supervised dosing rather than a fixed protocol
  • Adaptive monitoring approach

Where it loses points

  • No pricing shown publicly — you must complete intake to see cost
  • Compounding pharmacy partner not named
  • GLP-1 molecules not specified (semaglutide vs tirzepatide vs oral)
  • No LegitScript badge visible on the homepage
  • No FDA compounded-medication disclaimer on the pages reviewed
Ryze Rx

Graded #376 · C

Strengths

  • Compounded semaglutide and tirzepatide both $199/mo, with $499/$799 three-month bundles
  • Physician consultation, ongoing clinical support and discreet shipping included with each prescription
  • Broad catalog beyond GLP-1: TRT plus peptides (BPC-157, sermorelin, NAD+, retatrutide and more)
  • Free shipping, 24hr prescription turnaround, FSA/HSA eligible; care advertised in all 50 states

Where it loses points

  • Terms, Privacy Policy and HIPAA notice are dead links - no legal entity, refund policy or governing law disclosed
  • Pharmacy partners not named - only 'US-licensed compounding pharmacies'
  • Homepage advertises GLP-1s 'from $149/mo' but the catalog lists $199/mo
  • On-site '4.9/5, 2,400+ reviews' is self-reported, not an independently verified rating

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard